NCT03978624 2025-10-15
Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Active not recruiting
UNC Lineberger Comprehensive Cancer Center
University of Chicago
University of Cincinnati
Sohag University
University of Florence
The First Affiliated Hospital with Nanjing Medical University